The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Page 9

More JCP Articles

JCP
PTSD vs Other Conditions After Trauma and Life Stress Exposure
Original Research

May 12, 2025

In the longest study to date co-examining the environmental etiology of PTSD and MDD, trauma and life stress contributed to both conditions.
, , , et al
JCP
Intranasal Oxytocin and Alcohol Behavioral Couple Therapy
Original Research

May 12, 2025

Participants were romantic couples (n=49 oxytocin, n=47 placebo) consisting of a patient with AUD and their partner. Oxytocin was safe and tolerable but did not provide additional benefit beyond…
, , , et al
JCP
Preference for Lisdexamfetamine vs CBT for Binge-Eating Disorder
Original Research

May 7, 2025

CBT and pharmacotherapy with lisdexamfetamine resulted in significant improvements in binge-eating disorder. Participants’ preferences for treatments were not associated with sociodemographic or clinical characteristics and did not moderate treatment…
, , , et al
JCP
Lower Risk of Cardiovascular Disorders in Antidepressant-Treated Women Veterans: Encouraging Findings but Concerns Remain
Commentary

May 7, 2025

Comments on a study by Sumner et al that followed 609,546 women veterans for a mean of 8.8 years to look at associations of antidepressants with incident CVD.
JCP
Developing a Treatment-Resistant Depression Consultation Program, Part II: Assessment
Consensus Statement

May 7, 2025

Consensus recommendations about the goals of a consultation for treatment-resistant depression include establishing the primary diagnosis and comorbidities, clarifying symptoms, identifying goals, documenting treatment history, identifying treatment barriers, and…
, , , et al
JCP
Antidepressants and Incident Cardiovascular Disease in Women Veterans
Original Research

May 7, 2025

SSRIs, SNRIs, and other antidepressants were each associated with lower incidence of cardiovascular disease and stroke in this sample of women Veterans.
, , , et al
JCP
Vortioxetine for Cognitive Impairment in MDD Post-COVID
Original Research

May 5, 2025

Measures of cognitive function and depressive symptoms improved to a greater extent with vortioxetine than with escitalopram or sertraline in post-COVID syndrome participants with MDD.
, , , et al
JCP
Increased Risk of Suicide Attempt in Patients With Atopic Dermatitis
Original Research

May 5, 2025

People with atopic dermatitis had an elevated risk of suicide attempts, with an adjusted hazard ratio of 3.44.
, , , et al
JCP
Clozapine Monitoring in the Post-REMS World: Some Guidance for Clinicians
ASCP Corner

May 5, 2025

While the abolition of REMS for clozapine expands access, the change could create confusion. Among the most relevant examples are mismatches between FDA recommendations for lifetime monitoring and the…
,
JCP
Correction

May 2, 2025

JCP
Erecting Barriers to Suicide by Removing Barriers to Science
Letter to the Editor

April 30, 2025

The authors comment on the implications of a recent NSF communication warning researchers about the use of certain terms in grant proposals and publications made possible with government funding.
, , , et al
JCP
Adjunctive Cariprazine for Anxiety Symptoms in MDD
Original Research

April 30, 2025

Cariprazine added to antidepressant therapy reduced anxiety symptoms in patients with and without anxiety at baseline.
, , , et al

Consensus Report on XT Use in Practice

Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe